They required at least a few glances before one realized they were AI-generated, with avatar models strolling down a catwalk in front of a digitized audience that was flipped upside down.

Now I'm paying a heavy price for that delay. My cancer was diagnosed in June 1998 and has completely turned my life upside down. It has cost me my job, my sex life and any ability to plan for the ...

However, these three companies are ones I think could have among the most impressive upside potential this year, if a variety of catalysts take hold. Each company has their own unique catalysts I ...

The group consists of approximately 26 members and usually performs 3-4 shows per month. They often perform in Marquette County but have traveled all over the central and western Upper Peninsula ...

Medical Properties Trust and Rexford Industrial Realty have additional upside catalysts. Medical Properties Trust has battled a barrage of tenant-related issues over the past few years.

In a conservative view, I believe Volaris has 100% upside at this moment, thus my Buy rating in this article. Volaris is an Ultra-Low-Cost Carrier (ULCC) that operates mainly in the Mexican market ...

OppFi Inc. has remained under the radar for several years, though a recent breakout has started to gain investor interest. The company has significantly improved its financial standing, including ...

Severance season 2 is now available only on Apple TV+. Gwendoline Christie joins Severance season 2 in a significant role that adds depth to the series’ storyline. She portrays a Lumon employee ...

While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy. Many of the most ...

“It is a passion for me but it is not something I am willing to lose money on and I will turn heaven and earth upside down to make sure it’s profitable,” he said. Abhishek quit college in Boston in ...

Stocks and bonds staged a major turnaround this week thanks to a perfect storm of factors that recalibrated investor expectations for rate cuts in the coming year. The S&P 500 is on pace to soar ...

While 2024 was a “challenging” year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months. On November 28 ...